Resource Library | HIV New Product Introduction Toolkit

top of page

Resource Library

Sep 6

Pediatric DRV/r (pDRV/r) FAQs

Sep 6

Pediatric DRV/r (pDRV/r) Product Profile

Jul 29

CHAI ARV Approvals Database

Jun 7

2023 CHAI HIV Mid-Year Market Memo

Jun 5

Pediatric ALD (pALD) FAQs

May 31

Optimal CAB Case Study: Pediatric Dolutegravir

May 30

pALD Product Profile

May 30

Pediatric Treatment Optimization Roadmap

May 24

GAP-f pALD Introduction and Rollout Planning Considerations for National Programmes

May 16

CAB Case Studies from Ethiopia

May 4

The Transitioning Children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study

Mar 17

ARV Procurement Working Group Progress Review

Feb 27

Community Statements on DRV/r Use in 2L

Feb 16

CAB Case Studies from Tanzania

Feb 16

CAB Case Studies from Zambia

Feb 16

CAB Case Studies from Nigeria

Feb 16

CAB Case Studies from Uganda

Feb 16

CHAI Simple Tool Adults & Pediatrics

Feb 10

ARV Procurement Working Group Newsletters

Dec 16, 2022

2022 HIV Market Report

bottom of page